Cargando…

A new scoring system for predicting survival in patients with non-small cell lung cancer

This analysis was performed to create a scoring system to estimate the survival of patients with non-small cell lung cancer (NSCLC). Data from 1274 NSCLC patients were analyzed to create and validate a scoring system. Univariate (UV) and multivariate (MV) Cox models were used to evaluate the prognos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schild, Steven E, Tan, Angelina D, Wampfler, Jason A, Ross, Helen J, Yang, Ping, Sloan, Jeff A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567018/ https://www.ncbi.nlm.nih.gov/pubmed/26108458 http://dx.doi.org/10.1002/cam4.479

Ejemplares similares

Gastroesophageal reflux disease and paraneoplastic neurological syndrome associated with long‐term survival in limited stage small‐cell lung cancer
por: Ernani, Vinicius, et al.
Publicado: (2022)

Pretreatment Glasgow prognostic score predicts survival among patients with high PD‐L1 expression administered first‐line pembrolizumab monotherapy for non‐small cell lung cancer
por: Imai, Hisao, et al.
Publicado: (2021)

Predictive value of pretreatment albumin‐to‐alkaline phosphatase ratio for overall survival for patients with advanced non‐small cell lung cancer
por: Zhou, Shaozhang, et al.
Publicado: (2020)

Predictive factors for progression‐free survival in non‐small cell lung cancer patients receiving nivolumab based on performance status
por: Adachi, Yuichi, et al.
Publicado: (2019)

Copy‐number variation of MCL1 predicts overall survival of non‐small‐cell lung cancer in a Southern Chinese population
por: Yin, Jieyun, et al.
Publicado: (2016)

Stereotactic body radiotherapy improves the survival of patients with oligometastatic non‐small cell lung cancer
por: Ouyang, Wen, et al.
Publicado: (2019)

Prediction of prognosis of patients with lung cancer in combination with the immune score
por: Han, Ke, et al.
Publicado: (2021)

Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer‐specific survival of patients with kidney cancer
por: Zhou, Yuan, et al.
Publicado: (2020)

The impact of angiogenesis inhibitors on survival of patients with small cell lung cancer
por: Shi, Xiaoshun, et al.
Publicado: (2019)

Response to first‐line treatment predicts progression‐free survival benefit of small‐cell lung cancer patients treated with anlotinib
por: Qin, Boyu, et al.
Publicado: (2021)

Socioeconomic disparity trends in diagnostic imaging, treatments, and survival for non‐small cell lung cancer 2007‐2016
por: Shah, Monica, et al.
Publicado: (2020)

Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer
por: Bhateja, Priyanka, et al.
Publicado: (2019)

Impact of visceral pleural invasion on the association of extent of lymphadenectomy and survival in stage I non‐small cell lung cancer
por: Wo, Yang, et al.
Publicado: (2019)

Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience
por: Yu, Nathan Y., et al.
Publicado: (2019)

Survival trends among non‐small‐cell lung cancer patients over a decade: impact of initial therapy at academic centers
por: Lou, Yanyan, et al.
Publicado: (2018)

A validated survival score for patients with metastatic spinal cord compression from non-small cell lung cancer
por: Rades, Dirk, et al.
Publicado: (2012)

The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non‐small‐cell lung cancer patients
por: Wang, Suhan, et al.
Publicado: (2016)

Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non‐small cell lung cancer
por: Zhao, Qian, et al.
Publicado: (2021)

Real‐world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non‐small cell lung cancer
por: Jiang, Shirley Xue, et al.
Publicado: (2019)

Tumor suppressor properties of the small C-terminal domain phosphatases in non-small cell lung cancer
por: Krasnov, George S., et al.
Publicado: (2019)

Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy
por: Pataer, Apar, et al.
Publicado: (2018)

Comparison of Diagnosis-Specific Survival Scores for Patients with Small-Cell Lung Cancer Irradiated for Brain Metastases
por: Rades, Dirk, et al.
Publicado: (2019)

Identification of potential prognostic small nucleolar RNA biomarkers for predicting overall survival in patients with sarcoma
por: Liu, Jianwei, et al.
Publicado: (2020)

Development and validation of a nomogram based on stromal score to predict progression‐free survival of patients with papillary thyroid carcinoma
por: Tang, Jiajia, et al.
Publicado: (2021)

Ethnicity and insurance status predict metastatic disease presentation in prostate, breast, and non‐small cell lung cancer
por: Aghdam, Nima, et al.
Publicado: (2020)

Effects of thoracic radiotherapy timing and duration on progression‐free survival in limited‐stage small cell lung cancer
por: Zhao, Shen, et al.
Publicado: (2018)

The effect of prior cancer on non‐small cell lung cancer trial eligibility
por: Herman, Michael, et al.
Publicado: (2021)

Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab‐treated patients with advanced non–small cell lung cancer
por: Shiroyama, Takayuki, et al.
Publicado: (2017)

Albumin‐to‐fibrinogen ratio as a promising biomarker to predict clinical outcome of non‐small cell lung cancer individuals
por: Li, Shu‐Qi, et al.
Publicado: (2018)

Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score
por: Clive, Amelia O, et al.
Publicado: (2014)

Chemotherapy treatments, costs of care, and survival for patients diagnosed with small cell lung cancer: A SEER‐Medicare study
por: Shao, Changxia, et al.
Publicado: (2019)

Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database
por: Zhang, Rui, et al.
Publicado: (2018)

Oral fluorouracil vs vinorelbine plus cisplatin as adjuvant chemotherapy for stage II‐IIIA non‐small cell lung cancer: Propensity score‐matched and instrumental variable analyses
por: Urushiyama, Hirokazu, et al.
Publicado: (2018)

Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer
por: Yan, Xue, et al.
Publicado: (2020)

A novel LASSO‐derived prognostic model predicting survival for non‐small cell lung cancer patients with M1a diseases
por: Chen, Hongchao, et al.
Publicado: (2022)

Clinical significance of PET/CT uptake for peripheral clinical N0 non‐small cell lung cancer
por: Wang, Shuai, et al.
Publicado: (2020)

Modified Glasgow Prognostic Score at Recurrence Predicts Poor Survival in Resected Non-Small Cell Lung Cancer (NSCLC) Patients
por: Lv, Yongbin, et al.
Publicado: (2017)

Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non‐small cell lung cancer patients
por: Grenda, Anna, et al.
Publicado: (2019)

Identification of CXCL5 expression as a predictive biomarker associated with response and prognosis of immunotherapy in patients with non‐small cell lung cancer
por: Deng, Jie, et al.
Publicado: (2022)

Duration of nivolumab for pretreated, advanced non–small‐cell lung cancer
por: Geier, Margaux, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6onj6sfnoro6ubf1bnofgsqmob